Spedia® (NRL-1 / Diazepam Nasal Spray)
Epileptic Seizures / Status Epilepticus
ApprovedApproved in Japan (June 2025)
Key Facts
Indication
Epileptic Seizures / Status Epilepticus
Phase
Approved
Status
Approved in Japan (June 2025)
Company
About Aculys Pharma
A Japanese neuroscience biotech addressing drug lag by licensing and commercializing overseas-approved treatments for epilepsy and sleep disorders.
View full company profile